<ul><li>Size of the site: 92,300 m²</li><li>Buildings (total floor area): 14,670 m²</li><li>Production: 2,080 m²</li><li>Analytics: 320 m²</li><li>FTE: 67</li><li>Shifts: 8/5 or 16/5 (and alternatives)</li></ul>

<ul><li>Production of oral solid dosage forms in bulk<ul><li>Modified release pellets</li><li>Horse chestnut extract</li><li>Hard gelatin and HPMC capsules</li></ul></li><li>OEB 1-3</li><li>Quality services</li><li>Analytical services</li></ul>

<ul><li>Transfer</li><li>Scale-up</li><li>Granulation</li><li>Pelletisation</li><li>Modified release processes</li></ul>

<ul><li>Solid oral dosage forms in bulk</li></ul>

<ul><li>Manufacturing licenses<ul><li>EU GMP</li></ul></li><li>Non EU-GMP certificates<ul><li>SFDA (Saudi Arabia)</li><li>HCCH (Kazahkstan) </li><li>MFDS (Korea) </li><li>Belarusian MoH </li><li>Ministery of Health, Labour and Welfare (Japan)</li></ul></li><li>Health Products Regulatory Authority (Ireland) <ul><li>Manufacturing Authorization – Human Medicinal Products (M01042/00001) </li><li>Manufacturing Authorization – Active Substances (ASR11374/00001 (AUR19/029)</li><li>Manufacturing Authorization – Veterinary Medicinal Products (V13081/00001)</li></ul></li><li>ISO certificates<ul><li>ISO 14001</li></ul></li></ul>

<ul><li>Rx</li><li>OTC</li><li>Food supplements</li></ul>

Technologies

Manufacturing
<ul><li>Pellet/ granulate<ul><li>2 high shear granulators for use with organic solvents (1,200 litre, 360 kg batch size)</li><li>2 hot nitrogen fluid bed coater for use with organic solvents (400 kg batch size)</li><li>2 hot nitrogen fluid bed dryer for use with organic solvents (360 kg batch size)</li><li>2,500 litre blender (1,650 litre batch size)</li></ul></li><li>Encapsulation<ul><li>1 GKF2500 (pellet and powder filling)</li><li>2 GKF1500 (pellet filling) </li></ul></li><li>Horse chestnut extract<ul><li>1 horse chestnut extraction plant</li><li>1 hot nitrogen flat bottom spray dryer</li></ul></li></ul>

Products

Modified release pellets and hard capsules
<ul><li>Anti-inflammatory and anti-rheumatic </li><li>Bronchodilation </li><li>Vasoprotective</li><li>Proton pump inhibitor</li></ul>

Killorglin

The Aenova site in Killorglin has almost 50 years of experience in granulation, modified release coating, encapsulation, extraction and spray-drying.

The Aenova site in Killorglin has decades of expertise in the areas of pellet and granulate production and encapsulation. The innovative...

Killorglin - Aenova Group

employees

certifications & approvals

square meter

Encapsulation Killorglin Aenova

Killorglin Aenova

Blender Killorglin Aenova

Development Killorglin Aenova

Dryer Killorglin Aenova

Mixer Killorglin Aenova

Exterior view Killorglin Aenova

Aenova Site Killorglin Spray Drying & Pellets

Facts

Location Killorglin, Ireland
Competence Center for spray drying and modified release pellets

The Aenova site in Killorglin has almost 50 years of experience in granulation, modified release coating, encapsulation, extraction and spray-drying. As Competence Center for modified release pellets, our site in Killorglin produces and encapsulates particularly innovative types of pellets.
The spray drying development center continues to expand, providing a broad portfolio of applications, including solutions to enhance the bioavailability of APIs in oral solids.

Aenova launches new state-of-the-art spray drying platform at Killorglin site

21/07/2025 - Aenova launches new state-of-the-art spray drying platform at Killorglin site

Killorglin, 21/07/2025

Aenova is expanding its site in Killorglin with a spray drying platform for amorphous solid dispersions (ASD) and inhalation powders. The brand-new laboratory- and pilot-scale equipment is aimed at developing formulations for innovative drug candidates to overcome bioavailability hurdles, which are one of the greatest challenges in modern drug development. Spray drying as a core technology for improving bioavailability With approximately 80% of preclinical drug candidates facing bioavailability limitations due to poor solubility and permeability, Aenova is committed to unlocking the full therapeutic potential of these compounds. Aenova’s science-driven formulation strategies, including spray drying and hot melt extrusion for amorphous solid dispersions (ASDs), are designed to efficiently and effectively overcome such barriers. This accelerates the path from development to the market, ensuring that patients have faster access to innovative treatments. State-of-the-art spray drying capabilities With the new equipment at its Killorglin site, Aenova offers both laboratory-scale and pilot-scale spray drying capabilities, supplied by Büchi and GEA, enabling flexible development from early-stage research through to clinical supply. The project is supported by the Irish Government through IDA Ireland, and the expansion will also lead to the creation of new positions in the areas of R&D, pharmaceutical technology and analytics. The Aenova Killorglin site can handle active pharmaceutical ingredients (APIs) up to OEB 4, as well as organic solvents. “With nearly 50 years of experience in granulation, modified-release coating, encapsulation, extraction, and spray drying, the site provides customers with long-standing expertise and in-depth knowledge. Close collaboration with scientific researchers at the universities of Cork and Limerick promotes innovative, research-oriented approaches”, says Aidan Spillane, managing director at Aenova’s Killorglin site. “As an end-to-end CDMO, Aenova supports its customers throughout the entire drug product lifecycle, from pre-formulation and development to commercial manufacturing. Bioavailability plays a pivotal role in the success of new pharmaceutical compounds. With our new spray drying platform in Killorglin, we significantly expand our range of solutions to help customers overcome bioavailability hurdles and accelerate time-to-market,” says Florent Bordet, Chief Scientific Officer at Aenova. The opening ceremony took place on Friday, July 18, 2025.
<figure><img src="https://www.aenova-group.com/content/_medium/Aenova_Opening-Ceremony_Spray-drying.jpg" data-image="572938" alt="Opening Ceremony Killorglin"><figcaption>Florent Bordet, Chief Scientific Officer at Aenova, Michael Lohan, CEO of IDA Ireland, Norma Foley, Minister for Children, Disability and Equality and Aidan Spillane, Managing Director at the Aenova Killorglin site at the opening ceremony (Photo: IDA Ireland)</figcaption></figure>
<figure><img src="https://www.aenova-group.com/content/_medium/Aenova_Lab-scale-spray-drying_Killorglin.jpg" data-image="572939" alt="Spray Drying Killorglin lab-scale"><figcaption>Lab-scale spray drying development at Aenova Killorglin (Photo: Aenova)</figcaption></figure>

Auf einen Blick

At a glance

Jan Kengelbach

Dr. Peter Waller

Dr Peter Waller

Tim Bauer

Anne-Sophie Bonte, Ph.D.

Florent Bordet, Ph.D.

Florent Bordet, Ph. D.

Management

Aufsichtsrat

Supervisory Board

Bad Aibling

Carugate

Cornu

Feldkirchen

Greensboro

Gronau

Kirchberg

Latina

Marburg

Münster

Regensburg

Sisseln

Starnberg

Tittmoning

Standorte

Manufacturing Sites

Compliance

Nachhaltigkeit

Corporate Sustainability

Werte

Values

Ressourcen

Resources

Unternehmen

Company

Tablets

Hard Capsules & Pellets

Effervescents, Lozenges, Chewables

High potent solids

Controlled release

Beta Lactam Antibiotics

Solida

Solids

Liquid Vials

Prefilled Syringes

Beta Lactams

Fill & Finish of Biologics

Sterile Technologien

Sterile Technologies

Non-Sterile Liquids

Ointments and creams

Suppositories

Semisolida & nicht sterile Flüssigkeiten

Semi-solids & Non sterile Liquids

Soft Gelatin Capsules

VegaGels®

Gummies

Softgels & Gummies

Blisters

Vials

Bottles & Tubes, Cans & Jars

Cartons & Boxes

Services

Verpackungs-Services

Packaging Services

Qualität

Quality

Pharmazeutische Fertigung

Pharmaceutical Manufacturing

Semisolids & Liquids

Soft Gel Capsules

Sterile Injectables

Entwicklung von Arzneimitteln

Drug Product Development

Verbesserung Bioverfügbarkeit

Bioavailability Enhancement

Analytische Entwicklung

Analytical Development

Clinical Trial Supply Management

Regulatorische Unterstützung

Regulatory Support

Technologie Transfer

Technology Transfer

Entwicklung & Technologie

Development & Technology

Haustiere

Companion Animals

Nutztiere

Farm Animals

Tiergesundheit

Animal Health

Investoren

Investor Relations

Arbeiten bei Aenova

Working at Aenova

Karrierestufen

Career Levels

Ihre Bewerbung bei Aenova

Your application at Aenova

Job Portal

Karriere

Career

News

Events

News & Events

Presse Portal

Press Portal

Killorglin

The Production Plant

Manufacturing Services

Development Services

Packaging Services

Certifications & Approvals

Product Types

Address

News